Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry

Recruiting

• Conditions: Survival; Surgery; Radiotherapy; Drug Therapy; Neoplasms
• Interventions: Procedure: hospitalization

• Registration Number: NCT04996732
• Lead Sponsor: Fudan University

Brief Summary

Real-world studies on long-term prognosis in patients who underwent anti-tumor treatments during hospitalization from a hospital-based cancer registry in china.

Detailed Description

This is a single-center continuous enrollment cohort study. The overall survival and disease-free survival of patients with malignant tumors in the target tumor hospital undergoing surgery, radiotherapy, chemotherapy, and immunotherapy were observed. Follow-up methods include medical records review, telephone call interview, and data linkage to the related provincial death certificate registries. This study will provide real world data-sets for researches on long-term survival and prognosis of cancer patients, and expend exploration on the cancer survival determinants both from clinical and social-economic prospective.

Study Timeline

• Study Start: 2008-01-01
• Status Verified: 2021-08
• Study First Submitted: 2021-08-02
• Study First Submitted QC: 2021-08-02
• Last Update Submitted: 2021-08-02
• Study First Posted: 2021-08-09
• Last Update Posted: 2021-08-09
• Primary Completion: 2040-12-31
• Study Completion: 2041-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500000

Inclusion Criteria

• All patients who completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) due to malignant tumors based on preoperative or intraoperative evaluation in Fudan University Shanghai Cancer Center during the study period.

Read More

Exclusion Criteria

• Patients who have not been treated during hospitalization;
• Patients with non-malignant tumors.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
All Cancers	hospitalization	subgroups according to cancer sites

Primary Outcome Measures

Name	Time	Method
Overall survival	15 years	Death from any cause

Secondary Outcome Measures

Name	Time	Method
Disease-free survival	15 years	the time from treatment to recurrence of cancer, second primary cancer or death

Trial Locations

Locations (1)

Fudan University Shanghai Cancer Center; 🇨🇳 Shanghai, China